Profiling the HER3/PI3K Pathway in Breast Tumors Using Proximity-Directed Assays Identifies Correlations between Protein Complexes and Phosphoproteins
2011

Profiling the HER3/PI3K Pathway in Breast Tumors

Sample size: 27 publication Evidence: moderate

Author Information

Author(s): Mukherjee Ali, Badal Youssouf, Nguyen Xuan-Thao, Miller Johanna, Chenna Ahmed, Tahir Hasan, Newton Alicia, Parry Gordon, Williams Stephen

Primary Institution: Department of Oncology, Monogram Biosciences, South San Francisco, California, United States of America

Hypothesis

Can proximity-directed assays measure protein interactions and phosphorylation in breast cancer samples?

Conclusion

The study demonstrates that proximity-directed assays can effectively measure HER3/PI3K pathway activation in breast tumors.

Supporting Evidence

  • The study identified strong correlations between HER3 phosphorylation and receptor interactions.
  • 22 out of 27 breast tumors showed positive HER3PI3K assay results.
  • The assay system allows for quantitative measurement of therapeutic responses.

Takeaway

Researchers created a new test to see how proteins in breast cancer cells interact, which helps understand how to treat the disease better.

Methodology

The study used proximity-directed assays to measure protein interactions and phosphorylation in formalin-fixed, paraffin-embedded breast cancer samples.

Potential Biases

Potential bias due to funding from Monogram Biosciences, where all authors are employed.

Limitations

The study did not seek ethics committee approval as it did not involve human or animal experiments.

Participant Demographics

The study involved breast cancer cell lines and tumor samples, but specific demographics of participants were not detailed.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016443

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication